Uric acid is important, but there is something that matters even more: to deliver sacubitril/valsartan to eligible heart failure patients.
作者信息
Costanzo Maria Rosa
机构信息
Advocate Heart Institute, Naperville, IL, USA.
出版信息
Eur J Heart Fail. 2018 Mar;20(3):523-524. doi: 10.1002/ejhf.1087. Epub 2018 Jan 12.
PMID:29327807
Abstract
摘要
相似文献
1
Uric acid is important, but there is something that matters even more: to deliver sacubitril/valsartan to eligible heart failure patients.尿酸很重要，但还有更重要的事情：将沙库巴曲缬沙坦提供给符合条件的心力衰竭患者。
Eur J Heart Fail. 2018 Mar;20(3):523-524. doi: 10.1002/ejhf.1087. Epub 2018 Jan 12.
2
Sacubitril/Valsartan: potential treatment for paediatric heart failure.沙库巴曲缬沙坦：小儿心力衰竭的潜在治疗方法。
Cardiol Young. 2018 Sep;28(9):1077-1081. doi: 10.1017/S1047951118001014. Epub 2018 Jul 6.
3
▼ Sacubitril valsartan for heart failure.沙库巴曲缬沙坦用于治疗心力衰竭。
Drug Ther Bull. 2016 Jun;54(6):66-9. doi: 10.1136/dtb.2016.6.0405.
4
Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF.沙库巴曲缬沙坦降低了血清尿酸浓度，后者是 PARADIGM-HF 不良结局的独立预测因子。
Eur J Heart Fail. 2018 Mar;20(3):514-522. doi: 10.1002/ejhf.1056. Epub 2017 Nov 30.
5
Sacubitril/valsartan in PARADIGM-HF.沙库巴曲缬沙坦在PARADIGM-HF研究中的应用
Lancet Diabetes Endocrinol. 2017 Jul;5(7):495-496. doi: 10.1016/S2213-8587(17)30177-8.
6
Sacubitril/valsartan in PARADIGM-HF.沙库巴曲缬沙坦在PARADIGM-HF研究中的应用
Lancet Diabetes Endocrinol. 2017 Jul;5(7):495. doi: 10.1016/S2213-8587(17)30172-9.
7
Sacubitril/valsartan in PARADIGM-HF.沙库巴曲缬沙坦用于PARADIGM-HF研究
Lancet Diabetes Endocrinol. 2017 Jul;5(7):494-495. doi: 10.1016/S2213-8587(17)30173-0.
8
Sacubitril/valsartan: Can haemodynamic monitoring help with up-take?沙库巴曲缬沙坦：血流动力学监测有助于其应用吗？
Int J Cardiol. 2018 Nov 15;271:202-203. doi: 10.1016/j.ijcard.2018.05.059. Epub 2018 May 20.
9
Evaluation of Patients with Heart Failure to Determine Eligibility for Treatment with Sacubitril/Valsartan: Insights from a Veterans Administration Healthcare System.评估心力衰竭患者是否有资格接受沙库巴曲缬沙坦治疗：退伍军人医疗保健系统的见解。
Pharmacotherapy. 2019 Nov;39(11):1053-1059. doi: 10.1002/phar.2328. Epub 2019 Oct 10.
10
Sacubitril/valsartan in PARADIGM-HF - Authors' reply.沙库巴曲缬沙坦在PARADIGM-HF研究中的作者回复
Lancet Diabetes Endocrinol. 2017 Jul;5(7):496. doi: 10.1016/S2213-8587(17)30179-1.
Zotero 插件